Chemoinformaics analysis of (E)-4,8-Dimethyl-1,3,7-nonatriene
| Molecular Weight | 150.265 | nRot | 4 |
| Heavy Atom Molecular Weight | 132.121 | nRig | 3 |
| Exact Molecular Weight | 150.141 | nRing | 0 |
| Solubility: LogS | -3.929 | nHRing | 0 |
| Solubility: LogP | 4.042 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 30.3723 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.421 |
| Synth | 2.946 |
| Natural Product Likeliness | 2.659 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.012 |
| Pgp-sub | 0.006 |
| HIA | 0.003 |
| CACO-2 | -4.37 |
| MDCK | 0.000035 |
| BBB | 0.706 |
| PPB | 0.956488 |
| VDSS | 3.546 |
| FU | 0.0596185 |
| CYP1A2-inh | 0.73 |
| CYP1A2-sub | 0.621 |
| CYP2c19-inh | 0.236 |
| CYP2c19-sub | 0.913 |
| CYP2c9-inh | 0.062 |
| CYP2c9-sub | 0.909 |
| CYP2d6-inh | 0.12 |
| CYP2d6-sub | 0.673 |
| CYP3a4-inh | 0.039 |
| CYP3a4-sub | 0.282 |
| CL | 8.014 |
| T12 | 0.406 |
| hERG | 0.009 |
| Ames | 0.171 |
| ROA | 0.023 |
| SkinSen | 0.919 |
| Carcinogencity | 0.784 |
| EI | 0.987 |
| Respiratory | 0.955 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.830443 |